Albert Bourla, Pfizer CEO (Evan Vucci/AP Images)
July 6, 2021 07:08 AM EDT
Coronavirus

Covid-19 roundup: Is­rael and South Ko­rea ne­go­ti­ate vac­cine swap; Af­ter av­do­ral­imab fail­ure, In­nate aban­dons pan­dem­ic work

Josh Sullivan

Is­rael is ship­ping 700,000 dos­es of Pfiz­er-BioN­Tech’s mR­NA-based vac­cine to South Ko­rea for dos­es to be named lat­er.

South Ko­rea will send a ship­ment of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Biose­cure com­pro­mise could add ex­ec­u­tive re­view process for named com­pa­nies, sources say

Af­ter Unit­ed­Health­care CEO killing, health­care in­dus­try faces a new se­cu­ri­ty re­al­i­ty

Eli­av Barr de­fends Mer­ck­'s LaNo­va deal, but cau­tions VEGF bis­pecifics have yet to de­liv­er ma­ture da­ta

Lil­ly con­tin­ues to ex­pand its em­pire of GLP-1 fac­to­ries with new $3B build­out

GSK's third new pact of the week fo­cus­es on Alzheimer's with start­up Mu­na Ther­a­peu­tics

FDA spells out new ex­pe­dit­ed with­draw­al pro­ce­dures for ac­cel­er­at­ed ap­provals

A service from the Financial Times